TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
01 1TAPI Czech Industries s. r. o.
01 1Ergotamine tartrate "Teva"
01 1Israel
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Registration Number : 220MF10122
Registrant's Address : Ostravska 305/29, Komarov, 747 70 Opava, Czech Republic
Initial Date of Registration : 2008-04-28
Latest Date of Registration : 2008-04-28
A Ergotamine Tartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ergotamine Tartrate, including repackagers and relabelers. The FDA regulates Ergotamine Tartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ergotamine Tartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ergotamine Tartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ergotamine Tartrate supplier is an individual or a company that provides Ergotamine Tartrate active pharmaceutical ingredient (API) or Ergotamine Tartrate finished formulations upon request. The Ergotamine Tartrate suppliers may include Ergotamine Tartrate API manufacturers, exporters, distributors and traders.
click here to find a list of Ergotamine Tartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ergotamine Tartrate Drug Master File in Japan (Ergotamine Tartrate JDMF) empowers Ergotamine Tartrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ergotamine Tartrate JDMF during the approval evaluation for pharmaceutical products. At the time of Ergotamine Tartrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ergotamine Tartrate suppliers with JDMF on PharmaCompass.
We have 1 companies offering Ergotamine Tartrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
